T-Cell Immunotherapy for Cancer Pipeline Market Analysis Report T-Cell Immunotherapy for Cancer Pipeline Market | Page 4

5.1.1 Leukemia
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 Solid Tumours
5.2.1 Melanoma
5.2.2 Bladder Cancer
5.2.3 Kidney Cancer
5.2.4 Ovarian Cancer
5.2.5 Breast Cancer
5.2.6 Lung Cancer
6. Pipeline Analysis
7. Investments in T-Cell Immunotherapy
8. Key Player Analysis
8.1 Adaptimmune Therapeutics plc
View summary of this report @ http://www.radiantinsights.com/research/t-cell-
immunotherapy-for-cancer-pipeline-analysis
8.2 Juno Therapeutics, Inc.
8.3 Kite Pharma, Inc.
8.4 Novartis International AG
8.5 Tessa Therapeutics Pte Ltd.
8.6 Gradalis, Inc.
8.7 Immunovative Therapies, Ltd.
8.8 Lion Biotechnologies, Inc.
8.9 Atara Biotherapeutics, Inc.
8.10 Celgene Corporation
8.11 Cellular Biomedicine Group
Follow Us: